Macquarie Group’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-3,608
| Closed | -$60K | – | 2325 |
|
2022
Q3 | $60K | Sell |
3,608
-6,582
| -65% | -$109K | ﹤0.01% | 1902 |
|
2022
Q2 | $43K | Buy |
10,190
+5,152
| +102% | +$21.7K | ﹤0.01% | 2092 |
|
2022
Q1 | $48 | Hold |
5,038
| – | – | ﹤0.01% | 2150 |
|
2021
Q4 | $96K | Buy |
5,038
+878
| +21% | +$16.7K | ﹤0.01% | 1951 |
|
2021
Q3 | $138K | Buy |
4,160
+1,277
| +44% | +$42.4K | ﹤0.01% | 1873 |
|
2021
Q2 | $112K | Hold |
2,883
| – | – | ﹤0.01% | 1940 |
|
2021
Q1 | $139K | Buy |
2,883
+261
| +10% | +$12.6K | ﹤0.01% | 1816 |
|
2020
Q4 | $136K | Hold |
2,622
| – | – | ﹤0.01% | 1802 |
|
2020
Q3 | $70K | Hold |
2,622
| – | – | ﹤0.01% | 1870 |
|
2020
Q2 | $51K | Buy |
+2,622
| New | +$51K | ﹤0.01% | 1923 |
|
2019
Q1 | – | Sell |
-500
| Closed | -$2K | – | 2017 |
|
2018
Q4 | $2K | Hold |
500
| – | – | ﹤0.01% | 2200 |
|
2018
Q3 | $3K | Sell |
500
-67,101
| -99% | -$403K | ﹤0.01% | 2113 |
|
2018
Q2 | $889K | Buy |
67,601
+15,377
| +29% | +$202K | ﹤0.01% | 1214 |
|
2018
Q1 | $742K | Buy |
+52,224
| New | +$742K | ﹤0.01% | 1260 |
|